IASO THERAPEUTICS INC — Federal Contracts, Awards & Government Contractor Profile

About IASO THERAPEUTICS INC

Iaso Therapeutics is a biotechnology company focused on developing next-generation synthetic vaccines using a novel mQβ VLP platform to combat infectious diseases and antimicrobial resistance. The company aims to deliver broad-spectrum vaccines with rapid protection, room-temperature stability, and global scalability.

Development of next-generation synthetic vaccinesIntegration of precision synthetic antigens with mQβ VLP carrierRapid design-to-clinic timelinesSynthetic control for broad coverage and immune optimizationUp to 900 conjugation sites, high immunogenicity, and low anti-carrier responsesValidation by 20 third-party clinical trials using wtQβ VLP

Is this your company?

Claim IASO THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim IASO THERAPEUTICS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.